Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-31 22:39 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Drugs, Retail
--------------------------------------------------------------------
Snippet:
Novo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, "predictable" monthly prices.
--------------------------------------------------------------------